Regulation - Regulation, President and chief executive

Filter

Popular Filters

US FDA approves ALK and Merck’s Grastek sublingual tablet for grass allergy

US FDA approves ALK and Merck’s Grastek sublingual tablet for grass allergy

15-04-2014

The US Food and Drug Administration has approved the Biologic License Application for Grastek (Timothy…

ALK AbelloAllergologyAllergy treatmentBiologyGrastekGrazaxImmunologicalsMerck & CoMerck Research LaboratoriesPharmaceuticalPresident and chief executiveRegulationUSA

Back to top